Comparing single and dual antiplatelet therapies after heart surgery
Official title: Single Versus Dual Antiplatelet Therapy in Patients With Incomplete Revascularization After Coronary Artery Bypass Graft Surgery
Run by Campus Bio-Medico University · NCT03789916 · Data updated 2026-11-12
This study tests whether taking one or two types of blood-thinning medications after heart surgery helps patients who haven't had all their blood vessels fixed live longer and healthier.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Campus Bio-Medico University Academic / other |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | January 2, 2019 |
| Main results expected | August 1, 2021 |
| Study ends | December 31, 2026 |
| Registry record updated | July 21, 2022 |
| Trial ID | NCT03789916 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients who have undergone CABG and have been identified as having incomplete myocardial revascularization.
✕Probably not a fit
Patients with acute coronary syndrome within the last 12 months or those who cannot tolerate the medications involved will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the effectiveness of single antiplatelet therapy (SAPT) versus dual antiplatelet therapy (DAPT) in patients who have undergone coronary artery bypass grafting (CABG) and have incomplete revascularization. Participants will be randomly assigned to receive either SAPT or DAPT before hospital discharge, with DAPT being administered for 12 months. The primary goal is to evaluate cardiac-related mortality five years after discharge.
Why it matters
Potential benefit: If successful, this study could provide insights into the optimal antiplatelet therapy for patients with incomplete revascularization, potentially improving long-term cardiac outcomes.
How similar studies have gone: Previous studies have explored antiplatelet therapies in similar contexts, but this specific comparison of SAPT versus DAPT in incomplete revascularization is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients undergoing CABG, ± cardiopulmonary bypass, ± any associated cardiac procedures (valve replacement,...) * incomplete myocardial revascularization, defined by anatomic or functional criteria * obtained informed consent Exclusion Criteria: * acute coronary syndrome \< 12 months from surgery * dual antiplatelet therapy at hospital admission * planned procedure to complete myocardial revascularization (e.g. hybrid approach) * intolerance / unable to take acetylsalicylic acid or ticagrelor * preoperative atrial fibrillation * impaired compliance * planned pregnancy * history of gastrointestinal bleeding * chronic kidney disease (eGFR \< 30 mL/min/1.73 m2) * chronic liver disease * severe heart failure at hospital admission * active malignancy * alcohol abuse * any clinical condition not compatible with the treatment Exit Criteria: * postoperative atrial fibrillation requiring anticoagulation * postoperative hemorrhagic events (stroke, GI bleeding) * occurrence of contraindications to acetylsalicylic acid or ticagrelor * surgical treatment requiring DAPT withdrawn * patient decision
Where it's running
-
Università Campus Bio-Medico di Roma
Rome, Italy Recruiting
Study contacts
- Study coordinator: Antonio Nenna, MD
- Email: a.nenna@unicampus.it
- Phone: +393337014743
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.